Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas

Article

Abstract: Patient mortality rates have remained stubbornly high (40%) for the past 35 years in head and neck s

Palabras claves:

Autores:

Argueta C., Boros S., Daelemans D., De Long L.M., Gannon O.M., Hazar-Rethinam M., Jacquemyn M., Kashyap T., Landesman Y., Natalia Sáenz-Ponce, Panizza B., Pillay R., Saunders N.A.

Fuentes:

scopus